⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EVAX News
Evaxion A/S American Depositary Share
New data demonstrates the unique scalability of Evaxion’s AI-Immunology™ platform in glioblastoma
globenewswire.com
EVAX
Evaxion concludes Annual General Meeting
globenewswire.com
EVAX
Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01
globenewswire.com
EVAX
Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine Congress
globenewswire.com
EVAX
Notice to convene Evaxion’s Annual General Meeting
globenewswire.com
EVAX
Evaxion to present new data at AACR Annual Meeting
globenewswire.com
EVAX
Evaxion announces business update and full year 2025 financial results
globenewswire.com
EVAX
Evaxion plans to file 2025 annual report later today
globenewswire.com
EVAX
Evaxion to announce business update and full year 2025 financial results on March 5, 2026
globenewswire.com
EVAX
Cancer Immunotherapy Research Report 2026: Market Forecasts 2025-2029 for Immuno-Oncology Therapeutics by Therapy, Cancer and Customer with Executive and Consultant Guides
globenewswire.com
ABBV
ADAG
ADAP
ACET
ALXO
AMBR
AMGN
RCUS
AZN
ATRC
BBLU
BIIB
BNTX
BOLT
BMY
CRBU
CLDX
CRVS
LLY
EVAX
GNSS
GILD
GLSI
IMUX
IMMX
IMNM
INCY
INDP
ISRL
IOBT
JNJ
MRK
MRNA
MBIO
NVS
NVX
PDSB
PFE
REGN
SNY
SNT
URGN
ZYME